AS Kevelt announced that it will receive 2.2 million in its equity round of funding from existing investor, Open Joint-Stock Company Pharmsynthez on July 3, 2015. The transaction has been approved by the shareholders of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.505 RUB | +10.15% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 15M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- LIFE Stock
- News Pharmsynthez
- AS Kevelt announced that it expects to receive €2.2 million in funding from Open Joint-Stock Company Pharmsynthez.